Clinical Trials · NCT01957436
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- UNICANCER
- Enrollment
- 1,173
- Start date
- Nov 2013
- Locations
- 77 sites, 7 countries
- Primary endpoint
- Survival